The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diedrich, G.
Right arrow Articles by Cresswell, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diedrich, G.
Right arrow Articles by Cresswell, P.
The Journal of Immunology, 2001, 166: 1703-1709.
Copyright © 2001 by The American Association of Immunologists

A Role for Calnexin in the Assembly of the MHC Class I Loading Complex in the Endoplasmic Reticulum1

Gundo Diedrich, Naveen Bangia, Mary Pan and Peter Cresswell2

Section of Immunobiology, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06510


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Heterodimers of MHC class I glycoprotein and {beta}2-microglobulin ({beta}2m) bind short peptides in the endoplasmic reticulum (ER). Before peptide binding these molecules form part of a multisubunit loading complex that also contains the two subunits of the TAP, the transmembrane glycoprotein tapasin, the soluble chaperone calreticulin, and the thiol oxidoreductase ERp57. We have investigated the assembly of the loading complex and provide evidence that after TAP and tapasin associate with each other, the transmembrane chaperone calnexin and ERp57 bind to the TAP-tapasin complex to generate an intermediate. These interactions are independent of the N-linked glycan of tapasin, but require its transmembrane and/or cytoplasmic domain. This intermediate complex binds MHC class I-{beta}2m dimers, an event accompanied by the loss of calnexin and the acquisition of calreticulin, generating the MHC class I loading complex. Peptide binding then induces the dissociation of MHC class I-{beta}2m dimers, which can be transported to the cell surface.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The association of MHC class I-{beta}2-microglobulin ({beta}2m)3 dimers with peptides in the endoplasmic reticulum (ER) is a highly regulated process involving a number of interacting components (1). The peptides are generated in the cytosol, predominantly by proteasomal degradation, and translocated into the ER by the TAP, a heterodimeric ATP-dependent transporter. TAP is a component of a larger protein assembly, incorporating the TAP1 and TAP2 subunits, the MHC-encoded glycoprotein tapasin, the chaperone calreticulin, and the thiol oxidoreductase ERp57 as well as the MHC class I-{beta}2m dimer (2, 3, 4, 5). This assembly of proteins is often called the class I loading complex (6). Stoichiometric analysis has suggested that each MHC class I-{beta}2m dimer associates with a single tapasin molecule, and that four tapasin molecules may associate with a single TAP heterodimer (2). While the function of TAP is reasonably well understood, the roles of the additional components of the complex in MHC class I assembly are unclear.

Before their incorporation into the loading complex, MHC class I heavy chains can be found in association with the transmembrane chaperone calnexin and the ER Hsp70 homologue, BiP (7). These interactions are presumed to facilitate the initial folding of the class I heavy chain into a form that can associate with {beta}2m. After release from these chaperones, MHC class I heavy chains are incorporated into the loading complex. The order in which the various components are introduced into the loading complex, however, is unclear. One model is that preformed TAP-tapasin complexes act as receptors for newly assembled class I-{beta}2m dimers. Such complexes can exist independently of class I assembly in {beta}2m-negative cell lines, which is consistent with this. However, subcomplexes containing tapasin, class I-{beta}2m dimers, calreticulin and ERp57 can also exist independently of TAP in TAP-negative cell lines (3, 8), suggesting an alternative model in which tapasin binds to the class I molecule and the associated chaperones before its association with TAP. Regardless of the order of its assembly, however, the release of MHC class I-{beta}2m dimers from the loading complex is induced when they bind peptides (9, 10). The loaded MHC molecules satisfy the quality control criteria of the ER and are transported to the Golgi apparatus and ultimately to the cell surface.

Confusing the definition of the loading complex is work in the murine system from Williams and co-workers, in which calnexin was found to remain associated following class I-TAP interaction (11). Conversely, others confirmed the results obtained in the human system, observing that calreticulin was a component of the murine loading complex (12). Furthermore, although in the human system Abs to calnexin failed to coprecipitate the other components of the loading complex, calnexin was copurified when an anti TAP mAb was used to affinity purify the complex (2). Based on this we speculated that calnexin could be involved in the folding and assembly of the TAP-tapasin precursor required for generation of the complete loading complex.

In this paper we have analyzed the order and kinetics of assembly of the various components of the class I loading complex, investigated the interactions between them, and further investigated the role of calnexin in the assembly process.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Cells and Abs

The human cell lines HeLa M, a cervical carcinoma (13); 220.B8, a tapasin-deficient B-lymphoblastoid cell line (B-LCL), and its transfectants (14); T1 and T2, TxB cell hybrids (15); and Daudi, a {beta}2m-deficient Burkitt’s lymphoma, and the {beta}2m transfectant Daudi.{beta}2m (8), were maintained as previously described. The following previously described Abs were used: 148.3, an anti-TAP.1 mAb (16); w6/32, a {beta}2m-dependent anti-class I heavy chain mAb (17); HC10, a mAb recognizing free class I heavy chain (18); BM-63, an anti-{beta}2m mAb (Sigma, St. Louis, MO); AF8, an anti-calnexin mAb (19); MCP21, an anti-proteasome mAb (20); R.RING4C, a rabbit anti-peptide Ab to the C-terminal region of TAP.1 (21); rabbit anti-calreticulin antiserum (Affinity Bioreagents, Golden, CO); R.gp48N and R.gp48C, rabbit anti-peptide Abs to the N-terminal and C-terminal regions of tapasin, respectively (8, 22); and a rabbit anti-peptide Ab against calnexin (23). The new IgG1 mAb, MaP.ERp57, was generated by immunizing mice with recombinant ERp57 expressed in and purified from Escherichia coli (G. Diedrich and P. Cresswell, unpublished observations), and a conventional fusion was performed using spleen cells and the myeloma cell line, Ag.8. A rabbit antiserum recognizing ERp57, R.ERp57, was raised to the same recombinant product. The rabbit antiserum R.SinA was generated by immunizing rabbits with soluble tapasin expressed in and purified from insect cells using a baculovirus expression system (G. Diedrich and P. Cresswell, unpublished observations).

Radiolabeling, immunoprecipitation, and immunoblotting

HeLa M cells were induced with 200 U/ml human {gamma}-IFN (R&D Systems, Minneapolis, MN) for 48 h before radiolabeling. Cells were starved in methionine- and cysteine-free medium for 60 min, pulsed with [35S]methionine and [35S]cysteine at 1.25 mCi/ml (ICN, Costa Mesa, CA), and chased in medium containing excess methionine and cysteine (3 mM each). At various time points, the chase was stopped by diluting cells in ice-cold PBS. Solubilization and immunoprecipitations were performed as previously described (14). Unless otherwise indicated, the following number of cells were used per immunoprecipitation: HeLa M, 30 x 105; Daudi or Daudi.{beta}2m, 2 x 106; and T1, T2 and 220.B8 and its transfectants, 15 x 106. Cells were lysed in 0.15 M NaCl and 0.01 M Tris, pH 7.4 (TBS), containing 1% digitonin (Roche Diagnostics, Indianapolis, IN) or 1% Triton X-100 (Sigma) for 45 min. The postnuclear supernatant was precleared for 2 h with 3 µl of normal mouse serum and 30 µl of protein G-Sepharose (Amersham Pharmacia, Piscataway, NJ) before immunoprecipitation with 3 µg of Ab and 25 µl of protein G-Sepharose for 60 min. Precipitated proteins were separated by SDS-PAGE and analyzed by autoradiography. Stripping of precipitated proteins and reimmunoprecipitation with different Abs were performed as previously described (14). For the elution of TAP.1 from mAb148.3 or ERp57 from mAb MaP.ERp57, the immune complexes were incubated for at least 12 h in the presence of the peptide (0.1 mM in 1% digitonin/TBS) to which the mAb was raised or in recombinant ERp57 (100 µg/ml in 1% digitonin/TBS). Immunoblotting was performed as previously described (8).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Tapasin recruits calnexin and ERp57 to TAP-tapasin complexes

In the {beta}2m-negative cell line Daudi the assembly of the complete loading complex is prevented by the absence of {beta}2m (8, 24). TAP and tapasin still interact, but their association with class I heavy chain is strongly reduced (22). To identify proteins that assist the folding of or stabilize the TAP-tapasin complex, we isolated it from a digitonin extract of Daudi cells on an affinity column using mAb 148.3 as previously described (2). TAP1-associated proteins were eluted in 1% octylglucoside, which disrupts the TAP-tapasin interaction, and were analyzed by SDS-PAGE. Three major bands were stained with Coomassie blue and identified by N-terminal sequencing as calnexin, ERp57, and tapasin (data not shown). Calreticulin, which has a mobility similar to that of ERp57, was not present, in accordance with previous results (8).

To determine which components of the TAP-tapasin complex interact with calnexin and ERp57, Daudi cells were lysed in Triton X-100, which disrupts the TAP-tapasin interaction, or in digitonin, which preserves it. TAP and ERp57 were immunoprecipitated from the extracts, and the presence of associated calnexin and tapasin as well as calreticulin was analyzed by Western blotting. The experiment shown in Fig. 1GoA confirms that TAP, tapasin, ERp57, and calnexin form a complex in Daudi cells that is stable in digitonin. Calreticulin is not a component of this complex. In Triton X-100 lysates, calnexin was coprecipitated by an anti-ERp57 Ab (Fig. 1GoA), and by an anti-tapasin Ab (Fig. 1GoB). The ERp57 Ab also coprecipitated tapasin (Fig. 1GoA). None of these proteins was coprecipitated with a TAP1-specific Ab in the presence of Triton X-100. The results suggest that calnexin and ERp57 directly bind to tapasin within the TAP-tapasin complex. A similar analysis (Fig. 1GoA) of Daudi.{beta}2m was consistent with earlier results (2, 3, 8), which showed that, in the presence of {beta}2m, calreticulin and ERp57 detectably associate with TAP-tapasin complexes in digitonin and with tapasin in Triton X-100, consistent with coassociation of MHC class I molecules with these complexes.



View larger version (48K):
[in this window]
[in a new window]
 
FIGURE 1. Analysis of the components of the TAP-tapasin complex in Daudi ({beta}2m-negative), Daudi.{beta}2m, and .220. B8 cells expressing intact (wt), N-terminally truncated ({Delta}300), or soluble (sol) tapasin. The indicated cell lines were extracted in 1% Triton X-100 (A and B) or 1% digitonin (A–C). A, The extracts were precipitated with anti-TAP1 mAb 148.3, anti-ERp57 mAb MaP.ERp57, or normal mouse serum as a negative control. After separation by SDS-PAGE (10% acrylamide) and transfer to Immobilon-P membranes, the various proteins were detected with rabbit anti-calnexin serum, rabbit anti-TAP1 serum (R.RING4C), rabbit anti-calreticulin serum, or rabbit anti-tapasin serum (R.gp48N). B, Precipitating Abs were R.RING4C (anti-TAP1), R.gp48C (anti-tapasin), and normal rabbit serum as the negative control. AF8 (an anti-calnexin mAb) was used to probe the blot. C, Precipitating Abs were Rgp48C (rabbit anti-tapasin) and normal rabbit serum as the negative control. AF8 was again used to probe the blot.

 
Complexes of ERp57 with either calnexin or calreticulin catalyze the folding of immature glycoproteins. It is thought that the chaperone, rather than ERp57, provides the binding specificity by interacting with the N-linked glycans of the substrates and that the associated ERp57 catalyzes appropriate disulfide bond formation (25, 26, 27). There is also evidence from studies of mouse MHC class I molecules that calnexin may interact with transmembrane regions of membrane proteins (28). Tapasin is a transmembrane protein that also possesses an N-linked glycan. The influence of the N-linked glycan and the transmembrane domain of tapasin on the interaction with calnexin was analyzed using the tapasin-negative cell line .220.B8. We used transfectants expressing intact tapasin, soluble tapasin lacking the transmembrane domain, which is readily detectable by Western blots in cell extracts (14) (data not shown), or a truncated tapasin mutant lacking the N-terminal 300 aa and therefore lacking the single N-linked glycan (22). Calnexin was associated with the membrane-integrated truncated tapasin mutant, but did not detectably bind to soluble tapasin (Fig. 1GoC), suggesting that a stable interaction requires the tapasin transmembrane domain and that the N-linked glycan is not essential for the interaction. Consistent with this we have found that castanospermine, which inhibits glucosidase II and prevents the generation of monoglucosylated N-linked glycans, the substrate for calnexin, does not inhibit the calnexin-tapasin interaction (data not shown).

The binding of calnexin and MHC class I to TAP-tapasin complexes is mutually exclusive

The data in Fig. 1Go show that calnexin is associated with the TAP-tapasin complex in Daudi cells. It is also clear that calnexin still can be found in association with TAP when {beta}2m is introduced into Daudi or when tapasin is transfected into .220.B8 cells. These data and the earlier demonstration that calnexin copurified with the TAP complex from normal B-LCL (2) could be explained if a mixture of TAP-tapasin complexes, some containing MHC class I-{beta}2m dimers and some lacking class I but containing calnexin, were present in the purified material. To test this hypothesis, TAP1-containing complexes were affinity isolated from digitonin extracts of Daudi or Daudi.{beta}2m cells using the mAb 148.3. After release from the mAb by competitive peptide elution, the complexes were reprecipitated with mAbs specific for ERp57, {beta}2m or, as a negative control, the proteasome. The ERp57-specific mAb coprecipitated calnexin and tapasin from both Daudi-derived and Daudi.{beta}2m-derived TAP complexes, as analyzed by Western blotting (Fig. 2Go). The {beta}2m-specific mAb coprecipitated ERp57 and tapasin only from Daudi.{beta}2m cells, as expected. However calnexin was not coprecipitated with {beta}2m even from Daudi.{beta}2m-derived TAP complexes. Similar data were obtained using TAP complexes purified from HeLa M cells (not shown). Assuming that binding of TAP-associated class I-{beta}2m dimers with the {beta}2m-specific Ab is not affected by calnexin association, this suggests that two kinds of TAP-tapasin complexes exist in {beta}2m-expressing cells. One is calnexin free and contains class I molecules, and one contains calnexin and may correspond to complexes either in the process of folding and assembly or after dissociation of MHC molecules.



View larger version (28K):
[in this window]
[in a new window]
 
FIGURE 2. Calnexin is not a component of the complete class I loading complex. Daudi or Daudi.{beta}2m cells were lysed in 1% digitonin, and the TAP complex was immunoprecipitated with the mAb 148.3. Bound complexes were eluted by competition with specific peptide and reprecipitated with mAbs specific for ERp57 (MaP. ERp57) or {beta}2m (BM-63) or with a control mAb (MCP21). After separation by SDS-PAGE, proteins were transferred to an Immobilon-P membrane and probed with rabbit antisera to calnexin, ERp57 (R.ERp57), or tapasin (R.SinA).

 
Newly synthesized class I heavy chains rapidly associate with TAP1 and ERp57

To analyze the kinetics with which the various components are integrated into the class I loading complex, we performed pulse-chase experiments using IFN-{gamma}-induced HeLa M cells. These cells were used because the various components of the complex incorporate label more efficiently than in B-LCL. The cells were metabolically labeled for 3 min and chased in an excess of nonlabeled methionine for up to 75 min. TAP- and ERp57-associated proteins were recovered from digitonin lysates with mAbs 148.3 and MaP.ERp57, respectively (Fig. 3Go). Newly synthesized tapasin and class I heavy chains were found to associate rapidly with TAP. About 50% of the maximal level of each protein was bound to TAP at the beginning of the chase (0 min), and >90% was associated after a 15-min chase (Fig. 3GoD). It appears, therefore, that both proteins rapidly fold into a conformation that allows their association with TAP. The rates of dissociation of the different class I heavy chain isoforms from TAP differed significantly. The lower class I heavy chain band (HC2), which reacts predominantly with the mAb HCA2, disappeared with a half-time of approximately 90 min, whereas the upper band (HC1), which reacts predominantly with the mAb HC10, remained stably bound for >5 h (data not shown).



View larger version (44K):
[in this window]
[in a new window]
 
FIGURE 3. Newly synthesized class I heavy chain appears to associate faster than newly synthesized TAP and tapasin with ERp57. IFN-{gamma}-induced HeLa M cells were labeled with [35S]methionine for 3 min and chased for the indicated times. Extracts in 1% digitonin were immunoprecipitated with mAb 148.3 (TAP1 specific; A and B) or MaP.ERp57 (C), and the immunoprecipitates were separated by SDS-PAGE. B, The TAP complexes were eluted by specific peptide and reprecipitated with MaP.ERp57 before SDS-PAGE analysis. The intensities of the precipitated proteins were quantitated by image analysis (D and E). Values are the average of at least three independent experiments.

 
The signals for calreticulin and ERp57 were weak in a precipitation with the TAP1-specific mAb because the fraction of these proteins that is labeled is small compared with the already existing pools of nonlabeled proteins. To enhance the signal for these proteins, a 10-fold greater number of labeled HeLa M cells was used for the primary precipitation with the mAb 148.3, and the isolated TAP complexes were eluted with the peptide to which the mAb was raised. The complexes were then reprecipitated with MaP.ERp57 (Fig. 3GoB). The rates of association of calreticulin and ERp57 (unresolved on this gel) with TAP proved to be similar to the tapasin and class I heavy chain association rates, with >80% of the proteins bound to TAP after a 15-min chase (Fig. 3GoD).

The interaction of class I heavy chain with ERp57 followed kinetics similar to those of its interaction with TAP1 (Fig. 3Go, C and E). However, after a 15-min chase only 60% of labeled TAP and 40% of labeled tapasin were bound to ERp57. The delayed kinetics with which TAP and tapasin associate with ERp57, and the fact that the TAP-tapasin interaction occurs faster than the ERp57-tapasin interaction suggest that TAP and tapasin form a precomplex that has to fold into a specific conformation before ERp57 can be bound. The association rates of TAP, tapasin, and class I heavy chain with calreticulin and {beta}2m were very similar to their association rates with ERp57, i.e., the binding of TAP and tapasin was delayed compared with the binding of class I heavy chain (data not shown).

Class I heavy chain and ERp57 do not associate detectably in the absence of tapasin

The observation that newly synthesized class I heavy chains associate faster with ERp57 than with newly synthesized TAP and tapasin could be explained in two ways. First, class I heavy chain could interact with ERp57 independently of its association with the TAP-tapasin precomplex. Alternatively, the ERp57-class I heavy chain complex seen in the early time points of the chase period (when no or weak bands for TAP and tapasin are observed) could contain unlabeled TAP and tapasin. To address this question we looked for an ERp57-class I heavy chain interaction in TAP- and tapasin-negative cells. An interaction between ERp57 and class I heavy chain in a TAP-negative cell line was previously reported (3, 4). The existence of an ERp57-class I heavy chain complex in tapasin-negative cells is controversial. Lindquist et al. (4) described such a complex, whereas our laboratory failed to detect it (3). We used MaP.ERp57 (or a polyclonal antiserum, R.ERp57; data not shown) to precipitate ERp57 from digitonin extracts of metabolically labeled tapasin-negative cell lines, i.e., 220.B8, 220.B27 (Fig. 4Go), 220.A2, and 220.B44 (data not shown), and looked for coprecipitation of class I heavy chain. We could not detect any interaction between class I heavy chain and ERp57 in the absence of tapasin, whereas the interaction was easily detectable in the tapasin-transfectant 220.B8.tapasin (Fig. 4Go). Farmery et al. (29), using an in vitro translation system, observed that ERp57 interacts with class I heavy chains before complete oxidation of disulfide bonds. This may be difficult to observe in a conventional pulse-chase experiment such as that employed here.



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 4. The interaction between class I heavy chain and ERp57 is tapasin dependent. The tapasin-deficient cell lines 220.B8 and 220.B27 and the tapasin transfectant 220.B8.tapasin were radiolabeled for 15 min and lysed in 1% digitonin, and the extracts were immunoprecipitated with mAbs against class I heavy chain (HC10) or ERp57 (MaP.ERp57). When indicated, ERp57-associated proteins were eluted in SDS and DTT, and class I heavy chains (HC) were reprecipitated with HC10 or with normal mouse serum (ctrl) as a negative control. Isolated proteins were separated by SDS-PAGE and detected by fluorography.

 
The data suggest that all complexes we observed in the pulse-chase experiments that contain ERp57 and class I heavy chain must also contain TAP and tapasin. At the early time points nonlabeled TAP and tapasin predominate in the complexes, while at later time points labeled TAP and tapasin are incorporated. To verify this assumption we wanted to determine whether all the ERp57-associated class I heavy chain could be precipitated with Abs to TAP or tapasin. The pulse-chase experiment and the subsequent precipitation with the ERp57-specific mAb were repeated, but instead of analyzing the precipitated complexes directly, they were first eluted from the mAb with recombinant ERp57. The complexes were then reprecipitated with mAb 148.3 (against TAP1; Fig. 5Go) or with a rabbit antiserum against tapasin (R.gp48C; data not shown). All complexes between ERp57 and class I heavy chain recognized by MaP.ERp57 in the primary immunoprecipitation (Fig. 3GoC) were also recognized by the TAP1- and tapasin-specific Abs and therefore must contain TAP and tapasin.



View larger version (23K):
[in this window]
[in a new window]
 
FIGURE 5. All complexes of class I heavy chain and ERp57 contain TAP1. A, Lysates of HeLa M cells in 1% digitonin were immunoprecipitated with the mAb MaP.ERp57. Isolated complexes were competitively eluted with recombinant ERp57, reprecipitated with the anti TAP1 mAb 148.3, and subjected to SDS-PAGE. B, The intensities of the class I heavy chain bands were quantitated by image analysis. The ERp57-associated HC data are taken from Fig. 3GoC. Values are the average of two independent experiments.

 
Class I heavy chain does not form TAP-independent complexes with ERp57, calreticulin, or tapasin in wild-type cells

We took a more general approach to look for TAP-independent and ERp57-independent complexes that might contain class I heavy chain. HeLa M cells were labeled for 3 min and chased for either 7 min (Fig. 6Go, A–C) or 75 min (Fig. 6Go, D and E). The digitonin lysates were precleared with the TAP1-specific mAb 148.3 (Fig. 6Go, B and D) or with MaP.ERp57 (Fig. 6Go, C and E). To confirm the quantitative removal of TAP1-containing or ERp57-containing complexes, the precleared lysates were reprecipitated with the mAbs used for preclearing: no residual coprecipitated class I heavy chain or other bands were detected. Immunoprecipitations of the precleared lysates with mAb w6/32, which recognizes heavy chain-{beta}2m dimers that are not bound to TAP, confirmed that only TAP-associated or ERp57-associated proteins had been removed, since the intensities of the w6/32-precipitated proteins did not significantly change. Immunoprecipitations of the 148.3-precleared lysate with Abs against the individual components of the loading complex demonstrated that class I heavy chains were only precipitated by the {beta}2m-specific Ab (Fig. 6Go, B–E). Thus, except for the mature class I molecules recognized by the {beta}2m antiserum and those in the loading complex itself, no additional class I-containing complexes were found. If class I-containing complexes involving calreticulin, ERp57, or tapasin but lacking TAP exist, they must be much less abundant than the complete loading complex. Complexes containing these components are readily detectable in TAP-negative cells (3, 8), indicating that lack of Ab reactivity with such complexes is not a problem.



View larger version (56K):
[in this window]
[in a new window]
 
FIGURE 6. Class I heavy chain does not form TAP1-independent complexes with ERp57, calreticulin, or tapasin in wild-type cells. IFN-{gamma}- induced HeLa M cells were labeled with [35S]methionine for 3 min and chased for either 7 min (A–C) or 75 min (D and E). Extracts in 1% digitonin were precleared with normal rabbit serum and divided into three samples, which were either directly used for immunoprecipitation (A) or were extensively precleared with 148.3 (TAP1-specific; B and D) or MaP.ERp57 (C and E) coupled to Sepharose beads. The latter samples were then immunoprecipitated with mAbs against TAP1 (148.3), ERp57 (MaP.ERp57), calreticulin (rabbit antiserum), tapasin (R.gp48c), {beta}2m (rabbit antiserum), or MHC class I-{beta}2m dimers (w6/32). The immunoprecipitates were analyzed by SDS-PAGE followed by fluorography.

 
In Fig. 6Go, the amount of ERp57 and calreticulin present in the lysate after the 148.3-preclear did not decrease significantly, indicating that only a small fraction of the cellular pool of these proteins is associated with TAP. Because these molecules are housekeeping proteins, this is not unexpected. In contrast, tapasin was quantitatively removed after the 148.3-preclear (Fig. 6Go, B and D), suggesting that tapasin rapidly associates with TAP after synthesis and that there is no pool of free tapasin. Preclearing with the ERp57-specific mAb after a long chase removed the signal for class I heavy chain in subsequent immunoprecipitations with Abs against TAP1, calreticulin, or tapasin, indicating that there is no significant pool of class I heavy chain bound to TAP, calreticulin, or tapasin that does not contain ERp57 (Fig. 6Go, C and E). However, after a 7-min chase, tapasin could still be precipitated with a TAP1-specific mAb after the ERp57-preclear (Fig. 6GoC), supporting the conclusion from the pulse-chase experiments that TAP and tapasin form a precomplex without ERp57. At later times residual tapasin was not precipitated with the TAP.1-specific Ab after the ERp57 preclear, indicating that the labeled tapasin was now incorporated into complete ERp57-containing loading complexes (Fig. 6GoE).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The data presented here argue for an assembly pathway for the class I loading complex as schematized in Fig. 7Go. The first step involves the assembly of a complex containing TAP, tapasin, calnexin, and ERp57. The TAP.1 and TAP.2 subunits first associate with tapasin. Calnexin together with ERp57 then associates with the TAP-tapasin complex. Tapasin is required for the interaction of ERp57 with the complex (3), and differential detergent solubilization experiments indicate that tapasin is responsible for both ERp57 and calnexin association with the TAP-tapasin complex (Fig. 1GoB). The interaction does not require the N-linked glycan of tapasin based on studies with tapasin mutants (Fig. 1GoC). Soluble tapasin failed to detectably associate with calnexin, while a deletion mutant lacking the N-linked glycan did associate. Such a mutant could theoretically bind calnexin as a result of aggregation in the ER. However, we also found that castanospermine, which inhibits the enzyme glucosidase II and prevents generation of the monoglucosylated N-linked glycan substrate for calnexin, failed to inhibit the interaction of calnexin with the TAP-tapasin complex (data not shown). These data also argue that the N-linked glycan is not required for the interaction.



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 7. Model for the order of assembly of the MHC class I loading complex

 
Association of the TAP subunits with each other or with tapasin does not appear to require ERp57, as kinetic experiments suggest that TAP-tapasin association is detectable before their interaction with ERp57 (Fig. 6GoC). Whether there is an association with calnexin independent of ERp57 is difficult to determine, because no cell lines expressing calnexin but lacking ERp57 exist, and none of the Abs to calnexin we have used react with the chaperone while it is associated with the TAP-tapasin complex (8). Both calnexin and ERp57 can readily be found associated with the TAP-tapasin complex in the cell line Daudi (Fig. 1Go), where the absence of {beta}2m prevents the strong association of MHC class I molecules (22).

The TAP-tapasin complex containing calnexin and ERp57 appears to serve as the scaffold on which empty MHC class I molecules assemble. This involves the association of the class I heavy chain, {beta}2m, and calreticulin with the TAP-tapasin complex and the loss of calnexin. The association of calnexin and class I molecules with TAP appears to be mutually exclusive (Fig. 2Go). ERp57 is still found in the complex after class I association, but whether new ERp57 molecules associate together with newly introduced calreticulin molecules or whether the ERp57 shifts from a calnexin interaction to a calreticulin interaction within the complex is unclear. No class I heavy chains associated with other individual components of the complex, except {beta}2m, can be detected during assembly (Fig. 6Go). This is consistent with our previous suggestion (22) that the individual components of the loading complex interact in multiple ways in a highly cooperative manner. There may be transient interactions between members on the way to assembling the complete loading complex, but if they do occur they apparently do not survive detergent solubilization. The free class I heavy chains that partially fold before {beta}2m association and/or association with the loading complex have previously been shown to associate with calnexin and/or BiP (7, 8, 30).

After assembly of the complete loading complex, release of the associated MHC class I- {beta}2m dimers can be induced by the translocation of specific peptides into the ER by the TAP component (9). This indicates that peptide binding promotes class I release and disassembly of the loading complex, leaving the TAP-tapasin component available for the binding of new MHC class I- {beta}2m dimers. In Daudi cells, i.e., in the absence of {beta}2m, the TAP-tapasin complex contains calnexin and ERp57. The presence of these components at steady state is inconsistent with a simple role for the chaperones in assembly of the TAP-tapasin complex. It seems likely, rather, that the association of calnexin and ERp57 represents a transient intermediate in a loading cycle, and that this accumulates in Daudi cells because of the absence of {beta}2m. We suggest, as indicated in Fig. 7Go, that association of MHC class I molecules together with calreticulin with the TAP-tapasin complex induces the release of calnexin and further suggest that the class I molecules, in turn, are released when appropriate peptides are translocated and bind to them. ERp57 may dissociate and reassociate along with calnexin dissociation and calreticulin binding or remain associated, as discussed above. Although complexes containing class I, {beta}2m dimers, tapasin, calreticulin, and ERp57 can be found in TAP-negative cells (3, 8), they are not detectable in TAP-positive cells. The limiting component for the formation of such complexes may be tapasin, which rapidly associates with TAP under these circumstances.

Recent data from Howard and co-workers (10) suggests that ATP binding and hydrolysis by the cytoplasmic domains of TAP1 and TAP2 are required for the peptide-mediated release of class I molecules from the loading complex. Precisely how peptide translocation, peptide binding, and release of loaded class I molecules are coordinated is unclear. MHC class I molecules apparently not associated with TAP can be loaded with peptides (31), and HLA-A2 molecules in particular can bind signal sequence-derived peptides in TAP-negative cells (32). Soluble tapasin molecules, which bind class I-{beta}2m dimers, but do not appear to mediate the class I-TAP interaction, nevertheless permit class I peptide loading (14). It is also clear that although the experiments reported here point to a key role for calnexin in the assembly of the loading complex, MHC class I peptide loading can occur independently of calnexin (33, 34). The mechanisms that regulate MHC class I-peptide association and release from TAP-tapasin complexes after the loading complex is formed, and even the requirement for its formation, are far from clear.


    Acknowledgments
 
We thank Dr. Tobias Dick for critically reading the manuscript and Nancy Dometios for its preparation.


    Footnotes
 
1 This work was supported by the Howard Hughes Medical Institute. G.D. was supported by a Deutsche Forschungsgemeinschaft award. Back

2 Address correspondence and reprint requests to Dr. Peter Cresswell, Section of Immunobiology, Howard Hughes Medical Institute, Yale University School of Medicine, 310 Cedar Street, New Haven, CT 06510. Back

3 Abbreviations used in this paper: {beta}2m, {beta}2-microglobulin; B-LCL, B-lymphoblastoid cell line; ER, endoplasmic reticulum; TBS, 0.15 M NaCl and 0.01 M Tris, pH 7.4. Back

Received for publication September 1, 2000. Accepted for publication November 1, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Pamer, E., P. Cresswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323.[Medline]
  2. Ortmann, B., J. Copeman, P. J. Lehner, B. Sadasivan, J. A. Herbert, A. G. Grandea, S. R. Riddell, R. Tampe, T. Spies, J. Trowsdale, et al 1997. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277:1306.[Abstract/Free Full Text]
  3. Hughes, E. A., P. Cresswell. 1998. The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex. Curr. Biol. 8:709.[Medline]
  4. Lindquist, J. A., O. N. Jensen, M. Mann, G. J. Hammerling. 1998. ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly. EMBO J. 17:2186.[Medline]
  5. Morrice, N. A., S. J. Powis. 1998. A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules. Curr. Biol. 8:713.[Medline]
  6. Cresswell, P., N. Bangia, T. Dick, G. Diedrich. 1999. The nature of the MHC class I peptide loading complex. Immunol. Rev. 172:21.[Medline]
  7. Noessner, E., P. Parham. 1995. Species-specific differences in chaperone interaction of human and mouse histocompatibility complex class I molecules. J. Exp. Med. 181:327.[Abstract/Free Full Text]
  8. Sadasivan, B., P. J. Lehner, B. Ortmann, T. Spies, P. Cresswell. 1996. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5:103.[Medline]
  9. Androlewicz, M. J., B. Ortmann, P. M. van Endert, T. Spies, P. Cresswell. 1994. Characteristics of peptide and major histocompatibility complex class I/{beta}2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2). Proc. Natl. Acad. Sci. USA 91:12716.[Abstract/Free Full Text]
  10. Knittler, M. R., P. Alberts, E. V. Deverson, J. C. Howard. 1999. Nucleotide binding by TAP mediates association with peptide and release of assembled MHC class I molecules. Curr. Biol. 9:999.[Medline]
  11. Suh, W. K., E. K. Mitchell, Y. Yang, P. A. Peterson, D. B. Williams. 1996. MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains. J. Exp. Med. 184:337.[Abstract/Free Full Text]
  12. Van Leeuwen, J. E. M., K. P. Kearse. 1996. Deglucosylation of N-linked glycans is an important step in the dissociation of calreticulin-class I-TAP complexes. Proc. Natl. Acad. Sci. USA 93:13997.[Abstract/Free Full Text]
  13. Tiwari, R. K., J. Kusari, G. C. Sen. 1987. Functional equivalents of interferon-mediated signals needed for induction of an mRNA can be generated by double-stranded RNA and growth factors. EMBO 6:3373.[Medline]
  14. Lehner, P. J., M. J. Surman, P. Cresswell. 1998. Soluble tapasin restores MHC class I expression and function in the tapasin negative cell line .220. Immunity 8:221.[Medline]
  15. Salter, R. D., P. Cresswell. 1986. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO 5:943.[Medline]
  16. Meyer, T. H., P. M. Van Endert, S. Uebel, B. Ehring, R. Tampé. 1994. Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells. FEBS Lett. 351:443.[Medline]
  17. Parham, P., C. J. Barnstable, W. F. Bodmer. 1979. Use of monoclonal antibody (w6/32) in structural studies of HLA-A, B, C antigens. J. Immunol. 123:342.[Abstract/Free Full Text]
  18. Stam, N. J., H. Spits, H. L. Ploegh. 1986. Monoclonal antibodies raised against denatured HLA-B locus H-chains permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137:2299.[Abstract]
  19. Hochstenbach, F., V. David, S. Watkins, M. B. Brenner. 1992. Endoplasmic reticulum resident protein of 90 kilodaltons associates with the T-cell and B-cell antigen receptors and major histocompatibility complex antigens during their assembly. Proc. Natl. Acad. Sci. USA 89:4734.[Abstract/Free Full Text]
  20. Kaltoft, M. B., C. Koch, W. Uerkvitz, K. B. Hendil. 1992. Monoclonal antibodies to the human multicatalytic proteinase (proteasome). Hybridoma 11:507.[Medline]
  21. Ortmann, B., M. Androlewicz, P. Cresswell. 1994. MHC class I/{beta}2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368:864.[Medline]
  22. Bangia, N., P. J. Lehner, E. A. Hughes, M. Surman, P. Cresswell. 1999. The N-terminal region of tapasin is required to stabilize the MHC class I loading complex. Eur. J. Immunol. 29:1858.[Medline]
  23. Hammond, C., A. Helenius. 1994. Quality control in the secretory pathway: retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment and Golgi apparatus. J. Cell Biol. 126:41.[Abstract/Free Full Text]
  24. Solheim, J. C., M. R. Harris, C. S. Kindle, T. H. Hansen. 1997. Prominence of {beta}2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J. Immunol. 158:2236.[Abstract]
  25. Oliver, J. D., F. J. van der Wal, N. J. Bulleid, S. High. 1997. Interaction of the thiol-dependent reductase ERp57 with nascant glycoproteins. Science 275:86.[Abstract/Free Full Text]
  26. Elliott, J. G., J. D. Oliver, S. High. 1997. The thiol-dependent reductase ERp57 interacts specifically with N-glycosylated integral membrane proteins. J. Biol. Chem. 272:13849.[Abstract/Free Full Text]
  27. Zapun, A., N. J. Darby, D. C. Tessier, M. Michalak, J. J. M. Bergeron, D. Y. Thomas. 1998. Enhanced catalysis of ribonuclease B folding by the interaction of calnexin or calreticulin with ERp57*. J. Biol. Chem. 273:6009.[Abstract/Free Full Text]
  28. Margolese, L., G. L. Waneck, C. K. Suzuki, E. Degen, R. A. Flavell, D. B. Williams. 1993. Identification of the region of the class I histocompatibility molecule that interacts with the molecular chaperone p88 (calnexin, IP90). J. Biol. Chem. 268:17959.[Abstract/Free Full Text]
  29. Farmery, M. R., S. Allen, A. J. Allen, N. J. Bulleid. 2000. The role of ERp57 in disulfide bond formation during the assembly of major histocompatibility complex class I in a synchronized semipermeabilized cell translation system. J. Biol. Chem. 275:14933.[Abstract/Free Full Text]
  30. Williams, D. B., B. H. Barber, R. A. Flavell, H. Allen. 1989. Role of {beta}2 microglobulin in the intracellular transport and surface expression of murine class I histocompatibility molecules. J. Immunol. 142:2796.[Abstract]
  31. Neisig, A., R. Wubbolts, X. Zang, C. Melief, J. Neefjes. 1996. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 156:3196.[Abstract]
  32. Wei, M. L., P. Cresswell. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356:443.[Medline]
  33. Sadasivan, B. K., A. Cariappa, G. L. Waneck, P. Cresswell. 1995. Assembly, peptide loading, and transport of MHC class I molecules in a calnexin-negative cell line. Cold Spring Harbor Symp. 55:267.
  34. Scott, J. E., J. R. Dawson. 1995. MHC class I expression and transport in a calnexin-deficient cell line. J. Immunol. 155:143.[Abstract]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J.-M. Segura, P. Guillaume, S. Mark, D. Dojcinovic, A. Johannsen, G. Bosshard, G. Angelov, D. F. Legler, H. Vogel, and I. F. Luescher
Increased Mobility of Major Histocompatibility Complex I-Peptide Complexes Decreases the Sensitivity of Antigen Recognition
J. Biol. Chem., August 29, 2008; 283(35): 24254 - 24263.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
B. S. Ireland, U. Brockmeier, C. M. Howe, T. Elliott, and D. B. Williams
Lectin-deficient Calreticulin Retains Full Functionality as a Chaperone for Class I Histocompatibility Molecules
Mol. Biol. Cell, June 1, 2008; 19(6): 2413 - 2423.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Rufer, R. M. Leonhardt, and M. R. Knittler
Molecular Architecture of the TAP-Associated MHC Class I Peptide-Loading Complex
J. Immunol., November 1, 2007; 179(9): 5717 - 5727.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Raffaghello, P. Nozza, F. Morandi, M. Camoriano, X. Wang, M. L. Garre, A. Cama, G. Basso, S. Ferrone, C. Gambini, et al.
Expression and Functional Analysis of Human Leukocyte Antigen Class I Antigen-Processing Machinery in Medulloblastoma
Cancer Res., June 1, 2007; 67(11): 5471 - 5478.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Papadopoulos and F. Momburg
Multiple Residues in the Transmembrane Helix and Connecting Peptide of Mouse Tapasin Stabilize the Transporter Associated with the Antigen-processing TAP2 Subunit
J. Biol. Chem., March 30, 2007; 282(13): 9401 - 9410.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Leonhardt, K. Keusekotten, C. Bekpen, and M. R. Knittler
Critical Role for the Tapasin-Docking Site of TAP2 in the Functional Integrity of the MHC Class I-Peptide-Loading Complex
J. Immunol., October 15, 2005; 175(8): 5104 - 5114.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Zhu, J. Peng, D. Chen, X. Liu, L. Ye, H. Iijima, K. Kadavil, W. I. Lencer, and R. S. Blumberg
Calnexin and ERp57 Facilitate the Assembly of the Neonatal Fc Receptor for IgG with {beta}2-Microglobulin in the Endoplasmic Reticulum
J. Immunol., July 15, 2005; 175(2): 967 - 976.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. A. Kennedy, E. G. Gachelet, and B. Traxler
Evidence for Multiple Pathways in the Assembly of the Escherichia coli Maltose Transport Complex
J. Biol. Chem., August 6, 2004; 279(32): 33290 - 33297.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-E. Paquet, M. Cohen-Doyle, G. C. Shore, and D. B. Williams
Bap29/31 Influences the Intracellular Traffic of MHC Class I Molecules
J. Immunol., June 15, 2004; 172(12): 7548 - 7555.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Z. Frenkel, M. Shenkman, M. Kondratyev, and G. Z. Lederkremer
Separate Roles and Different Routing of Calnexin and ERp57 in Endoplasmic Reticulum Quality Control Revealed by Interactions with Asialoglycoprotein Receptor Chains
Mol. Biol. Cell, May 1, 2004; 15(5): 2133 - 2142.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ford, A. Antoniou, G. W. Butcher, and S. J. Powis
Competition for Access to the Rat Major Histocompatibility Complex Class I Peptide-loading Complex Reveals Optimization of Peptide Cargo in the Absence of Transporter Associated with Antigen Processing (TAP) Association
J. Biol. Chem., April 16, 2004; 279(16): 16077 - 16082.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. M. Tran, N. Satumtira, M. L. Dorris, E. May, A. Wang, E. Furuta, and J. D. Taurog
HLA-B27 in Transgenic Rats Forms Disulfide-Linked Heavy Chain Oligomers and Multimers That Bind to the Chaperone BiP
J. Immunol., April 15, 2004; 172(8): 5110 - 5119.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. L. Ackerman, C. Kyritsis, R. Tampe, and P. Cresswell
Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens
PNAS, October 28, 2003; 100(22): 12889 - 12894.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. L. Wilson and H. C. O'Neill
Identification of differentially expressed genes representing dendritic cell precursors and their progeny
Blood, September 1, 2003; 102(5): 1661 - 1669.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Radcliffe, G. Diedrich, D. J. Harvey, R. A. Dwek, P. Cresswell, and P. M. Rudd
Identification of Specific Glycoforms of Major Histocompatibility Complex Class I Heavy Chains Suggests That Class I Peptide Loading Is an Adaptation of the Quality Control Pathway Involving Calreticulin and ERp57
J. Biol. Chem., November 22, 2002; 277(48): 46415 - 46423.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-J. Kang and P. Cresswell
Calnexin, Calreticulin, and ERp57 Cooperate in Disulfide Bond Formation in Human CD1d Heavy Chain
J. Biol. Chem., November 15, 2002; 277(47): 44838 - 44844.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M.-E. Paquet and D. B. Williams
Mutant MHC class I molecules define interactions between components of the peptide-loading complex
Int. Immunol., April 1, 2002; 14(4): 347 - 358.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Pentcheva, E. T. Spiliotis, and M. Edidin
Cutting Edge: Tapasin Is Retained in the Endoplasmic Reticulum by Dynamic Clustering and Exclusion from Endoplasmic Reticulum Exit Sites
J. Immunol., February 15, 2002; 168(4): 1538 - 1541.
[Abstract] [Full Text] [PDF]


Home page